For research use only. Not for therapeutic Use.
DTG (Cat No.:I010312) is an antiretroviral medication used in the treatment of HIV infection. It is a second-generation integrase strand transfer inhibitor (INSTI) that works by blocking the HIV integrase enzyme, preventing the virus from integrating its genetic material into the host’s DNA. DTG is highly effective in reducing viral load and is often used as part of combination therapy for both treatment-naive and treatment-experienced patients. It has a favorable side-effect profile, long half-life, and is generally well-tolerated. DTG is a key drug in modern HIV management and has proven to be a cornerstone of antiretroviral regimens.
| Catalog Number | I010312 |
| CAS Number | 97-39-2 |
| Synonyms | 1,3-Di-(2-tolyl)guanidine |
| Molecular Formula | C15H17N3 |
| Purity | ≥95% |
| Target | Sigma Receptor |
| Solubility | Soluble to 25 mM in ethanol and to 25 mM in DMSO |
| Storage | Store at RT |
| IUPAC Name | 1,2-bis(2-methylphenyl)guanidine |
| InChI | InChI=1S/C15H17N3/c1-11-7-3-5-9-13(11)17-15(16)18-14-10-6-4-8-12(14)2/h3-10H,1-2H3,(H3,16,17,18) |
| InChIKey | OPNUROKCUBTKLF-UHFFFAOYSA-N |
| SMILES | CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N |
